Wednesday, July 8, 2026

pharma · Unstable Angina Pectoris · Gastric Carcinoma · COLL

COLLEGIUM PHARMACEUTICAL

Collegium Pharmaceutical is a pharma organization headquartered in Stoughton, USA. It trades on NYSE under ticker COLL. Primary therapeutic focus areas include Unstable Angina Pectoris, Gastric Carcinoma, aspirin-exacerb

100 Technology Center Dr, Stoughton, Massachusetts 02072, US HQ
617 Employees
Public company Type
COLL · NYSE Ticker
Company details
Status
Public
HQ
100 Technology Center Dr, Stoughton, Massachusetts 02072, US
Employees
617
Programs
29
Drugs
48
Patents
28
Clinical program

Platelet-rich plasma

Unknown · mab · ACL Injury

Platelet-rich plasma for ACL Injury is a Unknown program (mab) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).

Internal code NicolausCopernicusU

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
COLLEGIUM PHARMACEUTICAL, INC
Phase
Unknown
Modality
mab
Indication
ACL Injury
Status
active
Trials
1

Clinical trials